# Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity

> **NCT07715409** · NA · NOT_YET_RECRUITING · sponsor: **Mohamed Mousa Mohamed Mousa** · enrollment: 600 (estimated)

## Conditions studied

- Cesarean Section
- Surgical Site Infection
- Endometritis

## Interventions

- **DRUG:** Povidone-iodine 5% solution

## Key facts

- **NCT ID:** NCT07715409
- **Lead sponsor:** Mohamed Mousa Mohamed Mousa
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-05-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715409, "Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07715409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*